✦ LIBER ✦

Dolichyl phosphate dependent P-glycoprotein expression in Doxorubicin resistant MCF-7 breast cancer cells

✍ Scribed by I. Kuznecovs; S. Kuznecovs; K. Jegina; G. Kuznecova

Book ID: 119598736
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 85 KB
Volume: 6
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(08)71507-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dolichyl phosphate and polyprenol could

Dolichyl phosphate and polyprenol could inhibit P-glycoprotein in human MCF-7 breast cancer cells

✍ I. Kuznecovs; K. Jegina; S. Kuznecovs 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Gene expression alterations in doxorubic

Gene expression alterations in doxorubicin resistant MCF7 breast cancer cell line

✍ AbuHammad, Shatha; Zihlif, Malek 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 917 KB

330 P-glycoprotein in doxorubicin resist

330 P-glycoprotein in doxorubicin resistant MCF-7 breast cancer cells: DPAGT1 approach to N-glycosylation regulation

✍ I. Kuznecovs; G. Kuznecova; K. Jegina; S. Kuznecovs 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 62 KB

128 Genetic Expression Alterations in Do

128 Genetic Expression Alterations in Doxorubicin Resistant MCF7 Breast Cancer Cell-Line

✍ Zihlif, M.; AbuHammad, S.M. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Down-regulation of P-glycoprotein expres

Down-regulation of P-glycoprotein expression in MDR breast cancer cell MCF-7/ADR by honokiol

✍ Dong Xu; Qinghua Lu; Xun Hu 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 172 KB

Lack of modulation of MDR1 gene expressi

Lack of modulation of MDR1 gene expression by dominant inhibition of cAMP-dependent protein kinase in doxorubicin-resistant mcf-7 breast cancer cells

✍ Amadeo M. Parissenti; Brian R. Gannon; David J. Villeneuve; Angela F. Kirwan-rhu 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 172 KB 👁 2 views

The drug transporter P-glycoprotein (P-gp) appears to play an important role in the ability of tumor cells to evade killing by chemotherapeutic agents. Using pharmacological inhibitors of cAMP-dependent protein kinase (PKA), it has been suggested that, similar to rodent model systems, the human P-gp